SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-002294
Filing Date
2017-05-15
Accepted
2017-05-15 16:44:56
Documents
50
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm 10-Q 232739
2 CERTIFICATION curr_ex311.htm EX-31.1 8947
3 CERTIFICATION curr_ex312.htm EX-31.2 10062
4 CERTIFICATION curr_ex321.htm EX-32.1 3291
5 CERTIFICATION curr_ex322.htm EX-32.2 3245
  Complete submission text file 0001477932-17-002294.txt   1882915

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT curr-20170331.xml EX-101.INS 299207
7 XBRL TAXONOMY EXTENSION SCHEMA curr-20170331.xsd EX-101.SCH 36775
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20170331_cal.xml EX-101.CAL 36213
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20170331_def.xml EX-101.DEF 51750
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20170331_lab.xml EX-101.LAB 177528
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20170331_pre.xml EX-101.PRE 142107
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-204857 | Film No.: 17845042
SIC: 2673 Plastics, Foil & Coated Paper Bags